BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19068566)

  • 1. Regulatory inspection of clinical trials in Nigeria.
    Keri HJ
    Nig Q J Hosp Med; 2008; 18(2):120-2. PubMed ID: 19068566
    [No Abstract]   [Full Text] [Related]  

  • 2. They are from the government and they really are here to help you.
    Woosley RL
    J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
    [No Abstract]   [Full Text] [Related]  

  • 3. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 4. [The stakes of pre- and post-market authorization development and clinical assessment].
    Schwebig A
    Presse Med; 2012 May; 41 Suppl 1():S6-8. PubMed ID: 22483770
    [No Abstract]   [Full Text] [Related]  

  • 5. European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287.
    Flavell DJ; Flavell SU; Sullivan R
    Lancet; 2003 Oct; 362(9393):1415. PubMed ID: 14585646
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell and tissue therapy regulation: worldwide status and harmonization.
    Kellathur SN; Lou HX
    Biologicals; 2012 May; 40(3):222-4. PubMed ID: 22374355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The inspection by the Danish Medical Products Agency of drug clinical trials].
    Jacobsen E; Stilbo I
    Ugeskr Laeger; 2003 Apr; 165(16):1656-8. PubMed ID: 12756822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid drug access and scientific rigour: a delicate balance.
    The Lancet Neurology
    Lancet Neurol; 2021 Jan; 20(1):1. PubMed ID: 33340471
    [No Abstract]   [Full Text] [Related]  

  • 9. The gap between clinical trials and clinical practice: the use of pragmatic clinical trials to inform regulatory decision making.
    Brass EP
    Clin Pharmacol Ther; 2010 Mar; 87(3):351-5. PubMed ID: 20010554
    [No Abstract]   [Full Text] [Related]  

  • 10. Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.
    Wang Y; Bhattaram AV; Jadhav PR; Lesko LJ; Madabushi R; Powell JR; Qiu W; Sun H; Yim DS; Zheng JJ; Gobburu JV
    J Clin Pharmacol; 2008 Feb; 48(2):146-56. PubMed ID: 18199891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relevance of good research reporting.
    The Lancet Neurology
    Lancet Neurol; 2016 Oct; 15(11):1103. PubMed ID: 27647632
    [No Abstract]   [Full Text] [Related]  

  • 12. The lessons of failure: clinical flops are helping researchers define the keys to successful cancer drug trials.
    Nelson B
    Cancer Cytopathol; 2012 Dec; 120(6):359-60. PubMed ID: 23242934
    [No Abstract]   [Full Text] [Related]  

  • 13. Moment of reckoning.
    Wadman M
    Nature; 2007 Apr; 446(7138):844-5. PubMed ID: 17443154
    [No Abstract]   [Full Text] [Related]  

  • 14. Relocating abroad. FDA sends staff overseas to help monitor imports.
    Lee J
    Mod Healthc; 2011 Oct; 41(43):32. PubMed ID: 22111150
    [No Abstract]   [Full Text] [Related]  

  • 15. Addressing Conflict of Interest and Bias in Research, Education and Clinical Practice.
    Lau DC
    Can J Diabetes; 2015 Aug; 39(4):247-9. PubMed ID: 26116472
    [No Abstract]   [Full Text] [Related]  

  • 16. Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness.
    Corrigan-Curay J; Sacks L; Woodcock J
    JAMA; 2018 Sep; 320(9):867-868. PubMed ID: 30105359
    [No Abstract]   [Full Text] [Related]  

  • 17. Harmonization in the regulation of pharmaceutical research and human rights: the need to think globally.
    Dominguez-Urban I
    Cornell Int Law J; 1997; 30(2):245-86. PubMed ID: 12194190
    [No Abstract]   [Full Text] [Related]  

  • 18. Pediatric requirements in Europe stymie help for hemophilia.
    Peyvandi F; Rosendaal FR; O'Mahony B; Mannuccio Mannucci P
    Nat Med; 2014 Feb; 20(2):117. PubMed ID: 24504399
    [No Abstract]   [Full Text] [Related]  

  • 19. A regulatory perspective of clinical trial applications for biological products with particular emphasis on Advanced Therapy Medicinal Products (ATMPs).
    Jones DR; McBlane JW; McNaughton G; Rajakumaraswamy N; Wydenbach K
    Br J Clin Pharmacol; 2013 Aug; 76(2):203-9. PubMed ID: 23216470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials in status epilepticus-The clinical perspective.
    Kälviäinen R
    Epilepsia; 2009 Dec; 50 Suppl 12():75-6. PubMed ID: 19941534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.